Drugs / Enamel Matrix Protein
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05507047 | Jan 2017 → Jan 2020 | osteosclerosis | T.C. Dumlupınar Üniversitesi | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Enamel Matrix Protein | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05507047 ↗ |